3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
43
Head and Neck Neoplasms
35
Nasopharyngeal Carcinoma
19
Oropharyngeal Neoplasms
17
Carcinoma, Squamous Cell
15
Rectal Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Prostatic Neoplasms
11
Esophageal Squamous Cell Carcinoma
11
Mouth Neoplasms
8
Esophageal Neoplasms
8
Pancreatic Neoplasms
7
Laryngeal Neoplasms
7
Sarcoma
6
Tongue Neoplasms
5
Papillomavirus Infections
5
Lung Neoplasms
5
Hypopharyngeal Neoplasms
5
Glioblastoma
5
Brain Neoplasms
5
Stomatitis
4
Neoplasm Metastasis
4
Nasopharyngeal Neoplasms
4
Carcinoma
4
Breast Neoplasms
4
Uterine Cervical Neoplasms
3
Thyroid Carcinoma, Anaplastic
3
Lymphatic Metastasis
3
Gliosarcoma
3
Glioma
3
Interventions
Tamoxifen
12
Specimen Handling
6
Anastrozole
6
Chemotherapy, Adjuvant
5
Radiotherapy
4
Letrozole
4
afimoxifene
3
Mastectomy, Segmental
3
Surgical Procedures, Operative
2
Simvastatin
2
Radiation Dose Hypofractionation
2
Radiation
2
Fish Oils
2
Fatty Acids, Omega-3
2
4,17 beta-dihydroxy-4-androstene-3-one
2
telapristone acetate
1
sargramostim
1
ruxolitinib
1
polyphenon E
1
palbociclib
1
fezolinetant
1
exemestane
1
elacestrant
1
darolutamide
1
bazedoxifene
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Zoledronic Acid
1
Testosterone
1
Tea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Intraductal, Noninfiltrating
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT01185145
2013-07-11
APBI
Rocky Mountain Cancer Centers
Phase 2
Unknown
291 enrolled